Advisors Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.54M | Buy |
2,744
+142
| +5% | +$91.1K | 0.03% | 676 |
|
|
2025
Q4 | $1.76M | Buy |
2,602
+81
| +3% | +$55.2K | 0.03% | 634 |
|
|
2025
Q3 | $1.61M | Buy |
2,521
+75
| +3% | +$45.5K | 0.03% | 656 |
|
|
2025
Q2 | $1.31M | Sell |
2,446
-793
| -24% | -$379K | 0.02% | 690 |
|
|
2025
Q1 | $1.36M | Sell |
3,239
-119
| -4% | -$51.7K | 0.03% | 669 |
|
|
2024
Q4 | $1.39M | Buy |
3,358
+93
| +3% | +$40.8K | 0.03% | 651 |
|
|
2024
Q3 | $1.65M | Buy |
3,265
+131
| +4% | +$63.6K | 0.03% | 614 |
|
|
2024
Q2 | $1.53M | Buy |
3,134
+1,150
| +58% | +$577K | 0.03% | 615 |
|
|
2024
Q1 | $1.07M | Buy |
1,984
+434
| +28% | +$237K | 0.02% | 722 |
|
|
2023
Q4 | $860K | Sell |
1,550
-457
| -23% | -$215K | 0.02% | 755 |
|
|
2023
Q3 | $878K | Buy |
2,007
+176
| +10% | +$87.8K | 0.02% | 751 |
|
|
2023
Q2 | $920K | Sell |
1,831
-476
| -21% | -$228K | 0.02% | 769 |
|
|
2023
Q1 | $1.15M | Sell |
2,307
-56
| -2% | -$26.8K | 0.02% | 713 |
|
|
2022
Q4 | $964K | Sell |
2,363
-2,159
| -48% | -$838K | 0.02% | 757 |
|
|
2022
Q3 | $1.47M | Sell |
4,522
-106
| -2% | -$38.9K | 0.03% | 586 |
|
|
2022
Q2 | $1.62M | Sell |
4,628
-2,323
| -33% | -$947K | 0.03% | 583 |
|
|
2022
Q1 | $3.8M | Buy |
6,951
+724
| +12% | +$381K | 0.06% | 355 |
|
|
2021
Q4 | $4.1M | Buy |
6,227
+586
| +10% | +$368K | 0.06% | 358 |
|
|
2021
Q3 | $3.51M | Sell |
5,641
-405
| -7% | -$272K | 0.05% | 388 |
|
|
2021
Q2 | $3.82M | Sell |
6,046
-85
| -1% | -$46.9K | 0.06% | 351 |
|
|
2021
Q1 | $3M | Buy |
6,131
+1,186
| +24% | +$594K | 0.05% | 439 |
|
|
2020
Q4 | $2.47M | Buy |
4,945
+1,160
| +31% | +$519K | 0.04% | 461 |
|
|
2020
Q3 | $1.49M | Buy |
3,785
+1,491
| +65% | +$551K | 0.03% | 580 |
|
|
2020
Q2 | $757K | Buy |
2,294
+637
| +38% | +$184K | 0.01% | 765 |
|
|
2020
Q1 | $401K | Sell |
1,657
-107
| -6% | -$27.9K | 0.01% | 910 |
|
|
2019
Q4 | $461K | Buy |
1,764
+253
| +17% | +$66.7K | 0.01% | 1001 |
|
|
2019
Q3 | $411K | Buy |
1,511
+1,151
| +320% | +$320K | 0.01% | 1028 |
|
|
2019
Q2 | $99K | Buy |
+360
| New | +$88.7K | ﹤0.01% | 1311 |
|
|
2018
Q2 | – | Sell |
-696
| Closed | -$130K | – | 1603 |
|
|
2018
Q1 | $130K | Sell |
696
-547
| -44% | -$101K | ﹤0.01% | 1290 |
|
|
2017
Q4 | $194K | Sell |
1,243
-999
| -45% | -$157K | ﹤0.01% | 1252 |
|
|
2017
Q3 | $349K | Sell |
2,242
-117
| -5% | -$18.5K | 0.01% | 1148 |
|
|
2017
Q2 | $381K | Sell |
2,359
-514
| -18% | -$83.5K | 0.01% | 1161 |
|
|
2017
Q1 | $444K | Sell |
2,873
-7,289
| -72% | -$1M | 0.01% | 1143 |
|
|
2016
Q4 | $1.19M | Sell |
10,162
-856
| -8% | -$97.7K | 0.02% | 824 |
|
|
2016
Q3 | $1.24M | Sell |
11,018
-2,486
| -18% | -$262K | 0.02% | 790 |
|
|
2016
Q2 | $1.25M | Buy |
13,504
+5,805
| +75% | +$499K | 0.02% | 805 |
|
|
2016
Q1 | $603K | Sell |
7,699
-9,328
| -55% | -$672K | 0.01% | 1017 |
|
|
2015
Q4 | $1.24M | Buy |
17,027
+487
| +3% | +$34.7K | 0.02% | 821 |
|
|
2015
Q3 | $1.23M | Buy |
16,540
+5,948
| +56% | +$426K | 0.02% | 818 |
|
|
2015
Q2 | $679K | Sell |
10,592
-3,258
| -24% | -$226K | 0.01% | 1025 |
|
|
2015
Q1 | $1.07M | Sell |
13,850
-664
| -5% | -$51.7K | 0.01% | 851 |
|
|
2014
Q4 | $1.08M | Sell |
14,514
-176
| -1% | -$12.3K | 0.01% | 824 |
|
|
2014
Q3 | $865K | Sell |
14,690
-5,012
| -25% | -$317K | 0.01% | 846 |
|
|
2014
Q2 | $1.32M | Buy |
19,702
+518
| +3% | +$32.9K | 0.02% | 740 |
|
|
2014
Q1 | $1.16M | Sell |
19,184
-1,032
| -5% | -$61.5K | 0.02% | 717 |
|
|
2013
Q4 | $1.07M | Buy |
20,216
+188
| +0.9% | +$9.89K | 0.02% | 726 |
|
|
2013
Q3 | $998K | Sell |
20,028
-3,990
| -17% | -$192K | 0.02% | 675 |
|
|
2013
Q2 | $1.08M | Buy |
+24,018
| New | +$1.05M | 0.02% | 619 |
|
Other funds holding IDXX
VCM
VPM
Advisors Asset Management's IDXX Position: Q1 2026 in Review
Advisors Asset Management increased its Idexx Laboratories (IDXX) stake by 5.5% in Q1 2026, buying an estimated $91.1K and bringing the position to 2,744 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #676.
Advisors Asset Management first reported a position in IDXX in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.1M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Advisors Asset Management held 2,744 shares of Idexx Laboratories worth $1.54M as of Q1 2026.
- Advisors Asset Management bought 142 Idexx Laboratories shares in Q1 2026, an estimated $91.1K.
- Idexx Laboratories made up 0.03% of Advisors Asset Management's portfolio in Q1 2026, its #676 holding.
- Advisors Asset Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 48 quarters since.
- Advisors Asset Management's Idexx Laboratories position peaked at $4.1M in Q4 2021.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.